A61P 33 - Antiparasitic agents

Patents for A61P 33 - Antiparasitic agents (21,787)
11/2006
11/16/2006	CA2608061A1 Pharmaceutical composition including an anti-tumoral and an active ingredient selected among carveol, thymol, eugenol, borneol and carvacrol
11/16/2006	CA2607806A1 Modified interferon-gamma polypeptides and methods for using modified interferon-gamma polypeptides
11/16/2006	CA2606887A1 Pharmaceutical composition
11/15/2006	EP1720848A1 Derivatives of alkylpiperazine- and alkylhomopiperazine- carboxylates, preparation method thereof and use of same as faah enzyme inhibitors
11/15/2006	EP1720561A1 Botanical extract composition
11/15/2006	EP1423121B1 Cysteine protease inhibitors with 2-cyano-4-amino-pyrimidine structure and cathepsin k inhibitory activity for the treatment of inflammations and other diseases
11/15/2006	EP1324991B1 Compounds useful in the treatment of inflammatory diseases
11/15/2006	EP1009430B1 Oil in water emulsion vaccines against Hepatitis B
11/15/2006	CN1863788A Substances of antimicrobial, antifungoid and antiprotozoan activities
11/14/2006	US7135552 Useful as a candidate for a vaccine against ticks, particularly Ornithodoros moubata
11/14/2006	US7135471 Aryl oximes
11/14/2006	US7135464 Method of administering decitabine
11/09/2006	WO2006118605A2 8a, 9-dihydro-4a-h-isothiazolo[5,4-b] quinoline-3, 4-diones and related compounds as anti-infective agents
11/09/2006	WO2006117616A1 Polymorphic form i of lumefantrine and processes for its preparation
11/09/2006	US20060252915 Inhibit the growth of microorganisms in environments with physiological salt concentrations and at the same time have as low as possible a hemolytic activity
11/09/2006	US20060252800 Anti-leishmania agent
11/09/2006	US20060252792 Immunology for viral diseases and biosynthesis of cytokines of anticancer drugs for tumors
11/09/2006	CA2587485A1 8a, 9-dihydro-4a-h-isothiazolo[5,4-b] quinoline-3, 4-diones and related compounds as anti-infective agents
11/08/2006	EP1719775A1 Camptothecins with a modified lactone ring
11/08/2006	EP1242438B1 Cytotoxic agents comprising modified doxorubicins and daunorubicins and their therapeutic use
11/08/2006	CN1857655A Compound Chinese medicine preparation for clearing away heat, drying damp, disinsecting and relieving itch and its preparing process
11/08/2006	CN1857505A Tooth strengthening and pain stopping medicine powder
11/08/2006	CN1857498A Medicine for treating gynecopathy and its preparing method
11/08/2006	CN1857497A Erosion treating Chinese medicine ointment and its quality control method
11/08/2006	CN1857482A Compound Chinese medicine preparation for clearing away heat, drying damp, disinsecting and stopping itch and its preparing process
11/08/2006	CN1857390A Lotion for preventing and treating gynecopathy and its preparing method
11/08/2006	CN1857309A Nano silver spray for women and its preparing method
11/08/2006	CN1283805C Feeding assay for identifying nematicidal compounds
11/08/2006	CN1283251C Anthelminthic agents for prevention of parasitic infections in humans and animals
11/08/2006	CN1283241C Medicine for trichomonas vaginalis disease
11/08/2006	CN1283239C 1-amino-alkylcyclohexanes as trypanocidal agents
11/07/2006	US7132449 useful for the therapeutic treatment of Trypanosoma cruzi infection
11/07/2006	US7132447 Substance FKI-1083 and process for producing the same
11/07/2006	US7132431 Anti-malarial compounds
11/07/2006	US7132429 Sulfonamido ether substituted imidazoquinolines
11/07/2006	US7132403 Antihelminthic anthraquinones and method of use thereof
11/05/2006	CA2545778A1 Synthesis and antiprotozoal activity of dicationic 3,5-diphenylisoxazoles
11/02/2006	WO2006115188A1 Heterocyclic compound
11/02/2006	WO2005110384B1 Apiary veterinary composition
11/02/2006	US20060247448 zearalenone-like macrolides, used to to inhibit nuclear factor kappa-beta (NF- kappa B) activation, as sucnscreen agents and in the treatment of inflammatory or autoimmune disorders and disorders involving malignancy or increased angiogenesis
11/02/2006	US20060247290 Derivatives of dioxan-2-alkyl carbamates, preparation thereof and application thereof in therapeutics
11/02/2006	US20060247199 Methods and products for manipulating uncoupling protein expression
11/02/2006	EP1717237A1 Anthranilamides, process for the production thereof, and pest controllers containing the same
11/02/2006	EP1716178A1 Less immunogenic binding molecules
11/02/2006	EP1715883A1 18-membered nitrobenzyl-substituted and aminobenzyl-substituted cyclohexadepsipeptides for controlling endoparasites, and method for the production thereof
11/02/2006	EP1278525B1 Pyrophosphates for enhancing cellular function through protection of muscarinic receptors
11/02/2006	CA2605594A1 Heterocyclic compound
11/01/2006	CN1853731A Use of staphylococcal enterotoxin A gene and its coded protein
11/01/2006	CN1853635A Use of triazinetrione sulfones for combating coccidiosis
11/01/2006	CN1282452C Use of aminoadamantane compound as immunoregulators
10/2006
10/31/2006	US7129356 Farnesyl transferase inhibiting 4-substituted quinoline and quinazoline derivatives
10/31/2006	US7129349 Methods of synthesizing 3-amino-1,2,4-benzotriazines
10/31/2006	US7129241 Pyridazine derivatives
10/26/2006	WO2006111647A1 Association between ferroquine and an artemisinine derivative for treating malaria
10/26/2006	WO2006111085A1 A method, formulation and use thereor with improved oral absorption of drugs or nutrients
10/26/2006	US20060240491 Proteins involved in cytoadhesion of plasmodium falciparum ring-stage-infected erythrocytes, antibodies which bind to the proteins, and methods for detecting infection, stage of infection and vaccines for protecting against infection
10/26/2006	CA2605385A1 Combination of ferroquine and artesunate for the treatment of malaria
10/25/2006	EP1714969A2 Immunostimulatory nucleic acid molecules
10/25/2006	EP1714967A1 Antiparasitic artemisinin derivatives
10/25/2006	EP1713785A1 Halogenated biaryl heterocyclic compounds and methods of making and using the same
10/25/2006	EP1713468A1 Anthelmintic composition
10/25/2006	EP1713466A2 Antiparasitic composition containing an organic amine salt of closantel
10/25/2006	EP1509498B1 Pentafluorosulfanyl-benzoylguanidine, method for the production thereof and its utilization as medicament or diagnostic agent and medicament containing same
10/25/2006	EP1377275B1 Vaccine for modulating between t1 and t2 immune responses
10/25/2006	EP1259250B1 Endoparasiticidal agents
10/25/2006	EP1187613B9 Amide substituted imidazoquinolines
10/25/2006	CN1852709A Macrophage activation inhibitor
10/25/2006	CN1852708A Human beta-defensin secretion promoter
10/25/2006	CN1850849A 25-hydroxy dioscin ketone, and its preparing method and use
10/25/2006	CN1850086A Use of levo morpholine nidazole for preparing medicine for antiparasitic infection
10/25/2006	CN1281748C Gene of IL-12 p40 subunit mutated for improving activity of IL-12 and use thereof for DNA vaccine adjuvant
10/25/2006	CN1281273C Debilitating agent for highly toxic chicken coccidian and its preparation
10/25/2006	CN1281220C Lactic acid bacteria for treatment and/or prophylaxis of glardiasis
10/24/2006	US7125898 Kinase inhibitors to mediate disease and as antiinflammatory agents
10/24/2006	US7125890 Immunology for viral diseases and biosynthesis of cytokines of anticancer drugs for tumors
10/24/2006	US7125887 Pyrrolidine modulators of CCR5 chemokine receptor activity
10/24/2006	US7125883 alpha v beta 3 integrin receptor modulators; treating variety of diseases including cardiovascular disorders, retinopathy, strokes, cancer, osteoporosis, tumor metastasis, high blood pressure, psoriasis, antiviral, antimycotic, antiparasitic or antibacterial therapy; 1,2-dihydropyrimidin-2-one moiety
10/24/2006	US7125839 Chimeric molecules that contain at least one pathogen-detection domain and at least one effector domain; use in preventing or treating a pathogen infection in a cell or organism
10/24/2006	US7125699 for treating solid tumours, macular degeneration, corneal rejection, psoriasis, rheumatoid arthritis and chronic ulceration, and diseases involving vascular insufficiency, including stroke and following heart attack
10/24/2006	US7125557 Isolated haemocyanin polypeptide having a specific amino acid sequence recombinantly expressed in a host cell, wherein the glycosylation pattern is different from naturally occurring KLH from Megathura crenulata; may be bonded to a virus, bacteria, DNA, carbohydrate, peptide or glycoprotein
10/24/2006	CA2222517C Agents for use against parasitic protozoa
10/19/2006	WO2006110814A2 Methods for treating diseases through inhibition the function of molecular chaperones such as protein disulfide isomerases, pharmaceutical compositions comprising them, and screening methods for identifying therapeutic agents
10/19/2006	WO2006109069A1 Use of a metal ion chelating agent for the treatment of animal and human parasites
10/19/2006	WO2006108224A1 Antiparasitic compounds
10/19/2006	US20060235027 Inhibitors of cdc25 phosphatases
10/19/2006	US20060234905 Method of stimulating growth and resistance to diseases of aquatic organisms
10/19/2006	US20060233816 Use of plant oil-bodies in vaccine delivery systems
10/19/2006	US20060233811 Compositions and methods for treating cancer using immunoconjugates and chemotherapeutic agents
10/19/2006	DE102005018642A1 Use of ester compounds and/or compounds that are converted to ester compounds in organisms, in preparation of medicament for inhibition of cell proliferation by inhibiting reaction of glyoxalase I and/or II
10/19/2006	CA2606908A1 Use of a metal ion chelating agent for the treatment of animal and human parasites
10/19/2006	CA2604640A1 Methods for treating diseases through interruption of protein maturation, compounds that inhibit the function of molecular chaperones such as protein disulfide isomerases or interfere with glycosylation, pharmaceutical compositions comprising them, and screening methods for identifying therapeutic agents
10/18/2006	EP1712239A2 Interleukin-1 inhibitors in the treatment of diseases
10/18/2006	EP1712229A1 Fluconazole-tinidazole combination for the treatment of vaginal infections, composition thereof and preparation and use of same
10/18/2006	EP1280821B1 Dna molecules encoding ligand gated ion channels from dermacentor variabilis
10/18/2006	CN1846750A Groundcherry tincture and its prepn process
10/18/2006	CN1846508A Food containing Chinese fevervine material
10/18/2006	CN1280272C Spirocyclic 3-phenyl-3-substituted 4-ketolactams and 4-ketolactones
10/18/2006	CN1279937C Antiseptic and insect killing washing liquid and preparing method
10/17/2006	US7122669 Purine derivatives, preparation method and pharmaceutical compositions containing same
10/17/2006	US7122543 Substituted benzoic acid derivatives having NF-κB inhibiting action

1 ... 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 ... 218